FR2005291A1 - Heterocyclic amines, analgesic, antiinflammatory - Google Patents

Heterocyclic amines, analgesic, antiinflammatory

Info

Publication number
FR2005291A1
FR2005291A1 FR6909732A FR6909732A FR2005291A1 FR 2005291 A1 FR2005291 A1 FR 2005291A1 FR 6909732 A FR6909732 A FR 6909732A FR 6909732 A FR6909732 A FR 6909732A FR 2005291 A1 FR2005291 A1 FR 2005291A1
Authority
FR
France
Prior art keywords
antiinflammatory
analgesic
atoms
alkyl
heterocyclic amines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR6909732A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of FR2005291A1 publication Critical patent/FR2005291A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

(A) Cpds. of general formula (I) Het = a (5-6) membered heteroaromatic ring contng. 1 or 2, N, O, and/or S atoms X=H or (1-2C) alkyl Y=Ph opt. subst. by 1 or 2, F, Cl, and/or Br R1 and R2=H or (1-2C) alkyl R3=H or (1-4C) alkyl and where X, Y, and CR1R2.CH2NHR3 are attached to ring C atoms and Y and CR1R2CH2NHR3 are not on adjacent C atoms. (B) Acid addn. salts of I Anti-inflammatories, analgesics, and anti-pyretics. Dose 25-150 mg.
FR6909732A 1968-04-01 1969-03-31 Heterocyclic amines, analgesic, antiinflammatory Withdrawn FR2005291A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1553968A GB1188416A (en) 1968-04-01 1968-04-01 Heterocyclic Amines
GB1553969 1969-02-18

Publications (1)

Publication Number Publication Date
FR2005291A1 true FR2005291A1 (en) 1969-12-12

Family

ID=26251367

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6909732A Withdrawn FR2005291A1 (en) 1968-04-01 1969-03-31 Heterocyclic amines, analgesic, antiinflammatory

Country Status (5)

Country Link
BE (1) BE730833A (en)
DE (1) DE1913471A1 (en)
FR (1) FR2005291A1 (en)
GB (1) GB1188416A (en)
NL (1) NL6905060A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003291403A1 (en) * 2002-11-08 2004-06-03 Neurogen Corporation 3-substituted-6-aryl pyridined as ligands of c5a receptors
EP1741709A1 (en) 2005-06-28 2007-01-10 Sanofi-Aventis Deutschland GmbH Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB606714A (en) * 1945-11-21 1948-08-19 Ward Blenkinsop & Co Ltd Process for the production of 2-(aminoalkyl) pyrimidines and derivatives thereof
GB630671A (en) * 1945-07-11 1949-10-19 Ward Blenkinsop & Co Ltd Process for the production of amino alkyl thiazole derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB630671A (en) * 1945-07-11 1949-10-19 Ward Blenkinsop & Co Ltd Process for the production of amino alkyl thiazole derivatives
GB606714A (en) * 1945-11-21 1948-08-19 Ward Blenkinsop & Co Ltd Process for the production of 2-(aminoalkyl) pyrimidines and derivatives thereof

Also Published As

Publication number Publication date
GB1188416A (en) 1970-04-15
BE730833A (en) 1969-09-30
NL6905060A (en) 1969-10-03
DE1913471A1 (en) 1969-11-13

Similar Documents

Publication Publication Date Title
BE791693A (en) CONTINUOUS FEEDING MEDICAL NEBULIZER
ES412813A1 (en) 3-Substituted-1,2-benzisoxazoles and pharmaceutically acceptable acid addition salts thereof
ES415000A1 (en) Diphenylyl-al kanoylaminopyridines and salts thereof
FI50876C (en) Process for the preparation of therapeutically active N-substituted imidazoles and their salts.
FR2005291A1 (en) Heterocyclic amines, analgesic, antiinflammatory
CA997838A (en) Connector for use with a channel track supply
IL22831A (en) Embonic acid salts with dibenzazepine derivatives and a process for their preparation
ZA713181B (en) Tham salts of p.ge2and pgf2d
SE381874B (en) METHODS OF PREPARING PHARMACOLOGICALLY ACTIVE ANILINOBENSOTIAZOLES AND PHARMACOLOGICALLY ACCEPTABLE ACID ADDITIONAL SALTS THEREOF
FI48473C (en) Process for the preparation of a new soluble antibiotic active 2-5-desacetyl derivative with low toxicity of 4-guanylazo-4-deoxy-rifamycin SV.
PH10188A (en) 6-(l-3-acylamidoacetamido)-penicillanic acids,their pharmaceutically acceptable salts and their medicinal uses
ES369304A1 (en) IMIDAZO-3H-(4,5-b)-PYRIDINE DERIVATIVES
SE400775B (en) N-SUBSTITUTED 2,6-DIMETHYL-CHLOROACETANILIDES WITH GROWTH REGULATORY EFFECTS AND HERBICID EFFECTS, SPECIFICALLY USED AS SELECTIVE HERBICID
ES372209A1 (en) Alpha-{8 (phenyl sulfinyl)methyl{9 -alpha-phenyl derivatives of pyridinemethanols
ES368399A1 (en) Propanolamine derivatives
ES402774A1 (en) Combating nutsedge with 1-methyl-4-phenylpyridinium salts
FR2052993A1 (en) Alpha methimino benzyl penicillin alkaola - mine salts
FR1604911A (en) Amides and basic esters of 2-chloronicotinic acid - - with antiinflammatory and antispasmodic activity
GB1546757A (en) Crystalline cephalosporin salts
CA797846A (en) Tham salts
ES339025A1 (en) Diphenyl Derivatives
FR2014294A1 (en) 2-4-thiazolyl benzimidazole derivs anthelmintics
ES394968A1 (en) 5-(2-amino-alkoxy-phenoxy-methyl)-3-alkyl-isoxazoles - useful as hypotensives and sedatives
ZA723065B (en) New heterocyclic n,n-dioxides and their salts,their production,and their medicinal use
CA800607A (en) Preparation of organic salts in the presence of a carrier

Legal Events

Date Code Title Description
ST Notification of lapse